The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 12, 2022
Filed:
Jan. 11, 2017
Applicant:
Vetoquinol S.a., Lure, FR;
Inventors:
Francesco Bellini, Calgary, CA;
Alberto Salvaggio, Matelica, IT;
Angela Palumbo Piccionello, Matelica, IT;
Andrea Spaterna, Matelica, IT;
Nikolaos Loupis, Athens, GR;
Lise Hebert, Montreal, CA;
David Ohayon, Dollard-des-Ormeaux, CA;
Remigio Piergallini, San Benedetto del Tronto, IT;
Cecilia Vullo, Castelraimondo, IT;
Assignee:
VETOQUINOL S.A., Lure, FR;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 41/00 (2020.01); A61K 31/17 (2006.01); A61K 31/352 (2006.01); A61P 31/04 (2006.01); A61P 1/02 (2006.01); A61P 17/02 (2006.01); A61K 31/327 (2006.01); A61K 31/4166 (2006.01); A61K 31/7008 (2006.01); A61K 31/728 (2006.01); A61K 33/40 (2006.01); A61N 5/06 (2006.01);
U.S. Cl.
CPC ...
A61K 41/0057 (2013.01); A61K 31/17 (2013.01); A61K 31/327 (2013.01); A61K 31/352 (2013.01); A61K 31/4166 (2013.01); A61K 31/7008 (2013.01); A61K 31/728 (2013.01); A61K 33/40 (2013.01); A61N 5/062 (2013.01); A61P 1/02 (2018.01); A61P 17/02 (2018.01); A61P 31/04 (2018.01); A61N 2005/0651 (2013.01); A61N 2005/0662 (2013.01); A61N 2005/0663 (2013.01);
Abstract
The present document describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for use in the treatment of skin and soft tissue wounds that have either or both non-resistant and resistant infections.